GO:0090655 double-stranded/single-stranded junction telomeric DNA binding

Telomeres are specialized nucleoprotein structures at the ends of linear chromosomes that protect them from degradation and fusion. The telomeric DNA consists of a double-stranded region and a single-stranded G-rich 3' overhang, and the transition between these two domains forms a unique double-stranded/single-stranded (ds-ss) junction. The Gene Ontology term GO:0090655, double-stranded/single-stranded junction telomeric DNA binding, was created to capture the molecular function of proteins that specifically recognize this junction. This function is distinct from general single-stranded telomeric DNA binding or double-stranded telomeric DNA binding, and it is critical for chromosome end protection. Researchers study GO:0090655 because the ds-ss junction is a focal point for telomere regulation and a potential vulnerability in cancer cells. Proteins that bind this junction, such as human POT1, act as a cap that prevents the telomere from being recognized as a DNA double-strand break. Disruption of this binding can lead to telomere dysfunction, which is associated with cancer, aging, and other genome instability disorders. Understanding the molecular details of how proteins engage the ds-ss junction is therefore essential for both basic telomere biology and therapeutic development. This article provides a comprehensive overview of GO:0090655, including its definition, the major protein players, the structural and mechanistic basis of junction recognition, and the experimental methods used to study it. We also discuss how CRISPR-based models can be used to investigate the physiological consequences of perturbing this function.

GO:0090655, double-stranded/single-stranded junction telomeric DNA binding, is defined as the binding to a junction formed at the point where double-stranded telomeric DNA becomes a single-stranded G-rich telomeric DNA 3' overhang. In other words, it is the molecular function of specifically recognizing the transition zone between the double-helical and single-stranded regions of the telomere. This is a distinct binding activity that requires structural features of both the double-stranded and single-stranded telomeric DNA, as well as the junction itself.

GO:0090655 is important because the ds-ss junction is a critical structural element of telomeres, and its recognition by proteins such as POT1 is essential for protecting chromosome ends from being processed as DNA damage. Without this binding activity, telomeres become deprotected, leading to inappropriate DNA repair, end-to-end fusions, and genome instability. This function is therefore central to understanding how cells maintain genome integrity and how telomere dysfunction contributes to cancer and aging.

The following genes and proteins are directly or indirectly involved in double-stranded/single-stranded junction telomeric DNA binding and its associated functions.

The binding of proteins to the double-stranded/single-stranded junction telomeric DNA is regulated by the shelterin complex, particularly through the interaction between POT1 and TPP1. TPP1 recruits POT1 to telomeres and enhances its binding to the telomeric overhang. Additionally, post-translational modifications and the availability of other shelterin components can influence the stability and function of the POT1-TPP1 complex at the junction. The DNA damage response kinases ATM and ATR also play a role in signaling when this binding is compromised.

Disruption of double-stranded/single-stranded junction telomeric DNA binding, particularly through mutations in POT1, leads to telomere deprotection and genome instability, which are hallmarks of cancer. POT1 mutations have been identified in various cancers, including melanoma and chronic lymphocytic leukemia. Loss of junction binding can result in inappropriate DNA repair at telomeres, promoting oncogenic transformation.

Defects in proteins that bind the telomeric ds-ss junction can cause telomere biology disorders such as dyskeratosis congenita and related bone marrow failure syndromes. These conditions are characterized by short telomeres and impaired tissue regeneration. Studying GO:0090655 helps elucidate the molecular mechanisms underlying these disorders.

Telomere dysfunction due to impaired junction binding contributes to cellular senescence and aging. Animal models with disrupted POT1 function show premature aging phenotypes. Understanding how junction binding is regulated may provide insights into age-related diseases.

EMSA is used to detect the binding of proteins to the telomeric ds-ss junction DNA. By using oligonucleotides that mimic the junction, researchers can assess the specificity and affinity of proteins such as POT1 for this structure. This method is fundamental for studying GO:0090655 in vitro.

ChIP allows the detection of proteins bound to telomeric DNA in living cells. By using antibodies against POT1 or other shelterin components, researchers can determine whether they are associated with telomeric chromatin. This method provides in vivo evidence for junction binding.

Fluorescence microscopy, including immunofluorescence and live-cell imaging, can visualize the localization of junction-binding proteins at telomeres. Telomere-specific probes or tagged proteins can be used to assess co-localization. This approach helps confirm that binding occurs at chromosome ends.

CRISPR knockout screens can identify genes that are essential for telomere protection and junction binding. By selecting for cells that survive telomere dysfunction, researchers can uncover novel regulators of GO:0090655. This method is powerful for unbiased discovery.

Researchers studying double-stranded/single-stranded junction telomeric DNA binding-related genes often need to determine whether a candidate gene is causally involved in telomere protection and genome stability. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and knock-in models.

GO:0090655, double-stranded/single-stranded junction telomeric DNA binding, represents a critical molecular function for chromosome end protection. The specific recognition of the telomeric ds-ss junction by proteins such as POT1 is essential for preventing genome instability and is implicated in cancer and aging. Understanding the mechanisms and regulation of this binding activity provides insights into fundamental telomere biology and potential therapeutic targets. Researchers can leverage CRISPR-based models to dissect the physiological roles of junction-binding proteins and to test the consequences of disease-associated mutations. EDITGENE offers a full range of services to support these studies, from knockout and knock-in models to library screening and bioinformatics analysis.